Admission Date: [**2149-4-28**]        Discharge Date: [**2149-5-5**]  Date of Birth:  [**2110-1-16**]        Sex:  M  Service:   HISTORY OF PRESENT ILLNESS:  The patient is a 39 year old male with a past medical history of chronic myelogenous leukemia, status post unrelated allogeneic bone marrow transplant that has been complicated by chronic graft-versus- host disease (hypopigmentation, mild ulceration, and thrombocytopenia).
He denies any headache, rhinorrhea, pleuritic chest pain, nausea, vomiting, abdominal pain, changes in bowel or bladder habits.
He was seen by pulmonary who felt he had a component of Bronchlitis obliterans  and was treated with Prednisone 40 mg which was tapered slowly back down to 5 mg last month.
He is status post a match-unrelated allogeneic bone marrow transplant in [**2147-10-8**].
It has been complicated by graft-versus-host disease as mentioned above as well as cytomegalovirus colitis, bronchiolitis obliterans-organizing pneumonia, hemolytic uremic syndrome, and mouth ulcers as well as thrombocytopenia.
MEDICATIONS ON ADMISSION:  The patient's medications on admission are Prednisone 5 mg q. day and Acyclovir 400 mg p.o.
His white count is 7.4 with 46 percent neutrophils and 7 percent bands as well as 99 percent  lymphocytes.
The patient was transferred to the Medical Intensive Care Unit for aerosolized Ribavirin and Synagis treatment.
The patient received one dose of Synagis as well as a course of Ribavirin therapy which he tolerated well.
The patient received five days of Ribavirin in all.
Infectious disease consult was obtained for further assistance.
However, given the patient's immunocompromised status and out of concern for possible superimposed bronchitis or pneumonia, the patient was treated with a seven day course of Levofloxacin in addition to the treatment for his Ribavirin.
His prednisone dose was also increased to 40mg qd.
The patient received platelets on [**5-1**], as well as on [**4-29**], one unit.
Therefore Prednisone dose was increased to 40 mg q. day and was tapered slowly.
The patient's Prednisone dose is 30 mg at the time of discharge.
His hematocrit on admission was 29, the patient received 2 units of packed red blood cells on [**5-1**], and his hematocrit remained stable.
Status post allogeneic bone marrow transplant with extensive chronic graft-versus-host disease.
Acyclovir 400 mg p.o.
Folic acid 1 mg q. day.
Protonix 40 mg q. day.
Levofloxacin 500 mg q. day to complete his seven day    course.
Prednisone                             [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) **], MD [**MD Number(2) 9811**]  Dictated By:[**Last Name (NamePattern1) 8188**] MEDQUIST36 D:  [**2149-7-1**] 18:43:16 T:  [**2149-7-1**] 20:29:17 Job#:  [**Job Number 37210**]
